Solve Therapeutics Funding: $120M Raised, Series A (2021)
Solve Therapeutics is a Biotech company based in San Diego, California. It has raised $120M in total funding. Latest round: Series A.
Solve Therapeutics funding overview
Solve Therapeutics is a Biotech company based in San Diego, California. Solve Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Solve Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Yosemite, Abingworth, Merck, Alexandria Venture Investments, Surveyor Capital, Citadel. 6 distinct backers are named across the disclosed rounds.
Solve Therapeutics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Solve Therapeutics?
Yosemite, Abingworth, Merck, Alexandria Venture Investments, Surveyor Capital, Citadel are named among the investors backing Solve Therapeutics.
What was the latest Solve Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is Solve Therapeutics based?
Solve Therapeutics is based in San Diego, California.
What sector does Solve Therapeutics operate in?
Solve Therapeutics is tracked under Biotech from San Diego, California, with $120M in disclosed funding.
When did Solve Therapeutics last raise?
The last disclosed Solve Therapeutics round closed in January 2021 at Series A.
Solve Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Diego below to benchmark round size and investor mix.
